“The patient was managed with ripretinib and surgical resection of progressing lesions at multiple time points which led to extended clinical benefit.”...
Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) (FSE:0NFA) a biotechnology company engineering...
Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi Health” or the “Company”), a Canadian drug research and formulation company...
Several teachers at William Lyon Mackenzie Collegiate Institute in Toronto have returned to work after raising safety concerns regarding potential The...
EMBARGOED: Not for Release Until 00:01 AM (UK Time) on Friday 3 November 2023 Credit: Must credit NHS Blood and Transplant EMBARGOED: Not for Release Until...
The firm says its existing cash will fund it through 2025. The post Compass Pathways Research, Clinical Trials Buoyed by Influx of New Funds appeared first...
–Company to host conference call to discuss positive Phase 2 CYB003 interim results today, November 1, 2023 at 11:00 a.m. ET – – Complete Phase 2...
Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of innovative treatments to address mental...
It’s Obamacare open enrollment season, which means that, for people who rely on these plans for coverage, it’s time to shop around. With enhanced premium...
An international team of scientists led by researchers from the Department of Molecular Biosciences, The Wenner-Gren Institute, SciLifeLab, Stockholm University...